Research Article

Epidemiological Features and Predictors of Mortality in Patients with COVID-19 with and without Underlying Hypertension

Table 1

The characteristics of hypertensive and nonhypertensive patients with COVID-19.

VariableTotal (n = 40957)Hypertension (n = 1927)Nonhypertension (n = 39030) value
Number (%)Number (%)Number (%)

Age, median (IQR)37 (29–50)37 (29–50)61 (50–70)<0.001
Sex
Male23521 (57.42)781 (40.50)22740 (58.26)<0.003
Female17436 (42.58)1146 (59.50)16290 (41.74)
No-sign1753 (5.50)94 (4.90)1659 (4.25)0.130
Fever20717 (50.58)1163 (60.35)19554 (50.09)<0.001
Cough17787 (43.43)1032 (53.55)16755 (42.92)<0.007
Dyspnea12231 (29.86)782 (40.58)11449 (29.39)0.100
Muscular pain5948 (14.52)391 (20.29)5557 (14.23)0.100
Sore throat2872 (7.01)187 (9.70)2685 (6.88)0.350
Anorexia273 (0.57)59 (3.10)214 (0.55)<0.001
Headache1263 (3.08)170 (8.82)1093 (2.80)<0.001
Fatigue313 (0.76)92 (4.77)221 (0.56)0.001
Decreased sense of smell, taste2176 (5.31)55 (2.85)2121 (5.43)<0.001
Hypoxia2873 (7.01)194 (10.07)2679 (6.86)0.136
Comorbidities
Cardiovascular1998 (4.88)421 (21.84)1577 (4.04)<0.001
Diabetes2842 (6.94)828 (43)2014 (5.16)<0.001
Immunodeficiency389 (0.95)59 (3.06)330 (0.84)<0.001
Liver101 (0.25)10 (0.52)91 (0.23)0.090
Thyroid175 (0.43)101 (5.24)74 (0.19)0.001
Chronic kidney disease588 (1.43)124 (6.43)464 (1.19)<0.001
Chronic pulmonary disease988 (2.41)87 (4.50)901 (2.30)<0.001
Hospitalization history in ICU102 (0.25)29 (1.50)73 (0.19)<0.001
Exposure to disease26252 (64.10)1375 (71.35)24877 (63.74)<0.001
Mortality925 (2.26)253 (13.13)672 (1.72)<0.001